Literature DB >> 18998208

Mitochondrial dysfunction in neurodegenerative diseases.

Anthony H V Schapira1.   

Abstract

Mitochondria play a pivotal role in mammalian cell metabolism, hosting a number of important biochemical pathways including oxidative phosphorylation. As might be expected from this fundamental contribution to cell function, abnormalities of mitochondrial metabolism are a common cause of human disease. Primary mutations of mitochondrial DNA result in a diverse group of disorders often collectively referred to as the mitochondrial encephalomyopathies. Perhaps more importantly in numerical terms are those neurodegenerative diseases caused by mutations of nuclear genes encoding mitochondrial proteins. Finally there are mitochondrial abnormalities induced by secondary events e.g. oxidative stress that may contribute to senescence, and environmental toxins that may cause disease either alone or in combination with a genetic predisposition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18998208     DOI: 10.1007/s11064-008-9855-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  102 in total

Review 1.  Mitochondrial involvement in Parkinson's disease.

Authors:  M Orth; A H V Schapira
Journal:  Neurochem Int       Date:  2002-05       Impact factor: 3.921

2.  Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

Authors:  S J Tabrizi; M W Cleeter; J Xuereb; J W Taanman; J M Cooper; A H Schapira
Journal:  Ann Neurol       Date:  1999-01       Impact factor: 10.422

Review 3.  Novel pharmacological targets for the treatment of Parkinson's disease.

Authors:  Anthony H V Schapira; Erwan Bezard; Jonathan Brotchie; Frédéric Calon; Graham L Collingridge; Borris Ferger; Bastian Hengerer; Etienne Hirsch; Peter Jenner; Nicolas Le Novère; José A Obeso; Michael A Schwarzschild; Umberto Spampinato; Giora Davidai
Journal:  Nat Rev Drug Discov       Date:  2006-10       Impact factor: 84.694

4.  Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.

Authors:  R Lodi; J M Cooper; J L Bradley; D Manners; P Styles; D J Taylor; A H Schapira
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.

Authors:  A H Schapira; V M Mann; J M Cooper; D Dexter; S E Daniel; P Jenner; J B Clark; C D Marsden
Journal:  J Neurochem       Date:  1990-12       Impact factor: 5.372

6.  Parkin enhances mitochondrial biogenesis in proliferating cells.

Authors:  Yukiko Kuroda; Takao Mitsui; Makoto Kunishige; Masayuki Shono; Masashi Akaike; Hiroyuki Azuma; Toshio Matsumoto
Journal:  Hum Mol Genet       Date:  2006-01-31       Impact factor: 6.150

7.  Pyruvate dehydrogenase complex deficiency as a cause of subacute necrotizing encephalopathy (Leigh disease).

Authors:  H A Kretzschmar; S J DeArmond; T K Koch; M S Patel; C J Newth; K A Schmidt; S Packman
Journal:  Pediatrics       Date:  1987-03       Impact factor: 7.124

8.  Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson's disease.

Authors:  Jan-Willem Taanman; Anthony H V Schapira
Journal:  Neurosci Lett       Date:  2004-12-08       Impact factor: 3.046

9.  Brain lesions of the Leigh-type distribution associated with a mitochondriopathy of Pearson's syndrome: light and electron microscopic study.

Authors:  I Yamadori; A Kurose; S Kobayashi; M Ohmori; T Imai
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency.

Authors:  V Tiranti; K Hoertnagel; R Carrozzo; C Galimberti; M Munaro; M Granatiero; L Zelante; P Gasparini; R Marzella; M Rocchi; M P Bayona-Bafaluy; J A Enriquez; G Uziel; E Bertini; C Dionisi-Vici; B Franco; T Meitinger; M Zeviani
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

View more
  26 in total

1.  Evaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine.

Authors:  Fernanda Martins Lopes; Giovana Ferreira Londero; Liana Marengo de Medeiros; Leonardo Lisbôa da Motta; Guilherme Antônio Behr; Valeska Aguiar de Oliveira; Mohammad Ibrahim; José Cláudio Fonseca Moreira; Lisiane de Oliveira Porciúncula; João Batista Teixeira da Rocha; Fábio Klamt
Journal:  Neurotox Res       Date:  2012-01-20       Impact factor: 3.911

2.  Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Andrew Ferree; Katelyn Smith; Eugenio Barone; Marzia Perluigi; Raffaella Coccia; William Pierce; Jian Cai; Cesare Mancuso; Rachel Squillace; Manfred Wiengele; Isabella Dalle-Donne; Benjamin Wolozin; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2012-03-20       Impact factor: 8.401

3.  Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1.

Authors:  Guido Krebiehl; Sabine Ruckerbauer; Lena F Burbulla; Nicole Kieper; Brigitte Maurer; Jens Waak; Hartwig Wolburg; Zemfira Gizatullina; Frank N Gellerich; Dirk Woitalla; Olaf Riess; Philipp J Kahle; Tassula Proikas-Cezanne; Rejko Krüger
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

4.  Frataxin deficiency impairs mitochondrial biogenesis in cells, mice and humans.

Authors:  Mittal J Jasoliya; Marissa Z McMackin; Chelsea K Henderson; Susan L Perlman; Gino A Cortopassi
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

Review 5.  Metabolic disturbances in diseases with neurological involvement.

Authors:  João M N Duarte; Patrícia F Schuck; Gary L Wenk; Gustavo C Ferreira
Journal:  Aging Dis       Date:  2013-11-30       Impact factor: 6.745

6.  Differential impairment of catecholaminergic cell maturation and survival by genetic mitochondrial complex II dysfunction.

Authors:  Blanca Díaz-Castro; C Oscar Pintado; Paula García-Flores; José López-Barneo; José I Piruat
Journal:  Mol Cell Biol       Date:  2012-06-18       Impact factor: 4.272

7.  Autophagy-dependent rhodopsin degradation prevents retinal degeneration in Drosophila.

Authors:  Ryosuke Midorikawa; Miki Yamamoto-Hino; Wakae Awano; Yoshimi Hinohara; Emiko Suzuki; Ryu Ueda; Satoshi Goto
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

8.  Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes.

Authors:  Vittorio Calabrese; Carolin Cornelius; Anna Maria Giuffrida Stella; Edward J Calabrese
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

9.  Signaling pathway networks mined from human pituitary adenoma proteomics data.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2010-04-28       Impact factor: 3.063

10.  Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins.

Authors:  Patrícia Schönhofen; Liana M de Medeiros; Ivi Juliana Bristot; Fernanda M Lopes; Marco A De Bastiani; Flávio Kapczinski; José Alexandre S Crippa; Mauro Antônio A Castro; Richard B Parsons; Fábio Klamt
Journal:  Mol Neurobiol       Date:  2014-08-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.